Quantitative Investment Management, LLC recently filed their 13F report for the second quarter of 2022, which ended on 2022-06-30.
The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.
401 E. MARKET STREET CHARLOTTESVILLE, VA 22902
As of the latest 13F report, the guru’s equity portfolio contained 207 stocks valued at a total of $656.00Mil. The top holdings were GLD(8.47%), GDX(4.54%), and XLY(3.70%).
According to GuruFocus data, these were Quantitative Investment Management, LLC’s top five trades of the quarter.
S&P 500 ETF TRUST ETF
The guru sold out of their 827,335-share investment in ARCA:SPY. Previously, the stock had a 40.37% weight in the equity portfolio. Shares traded for an average price of $408.8 during the quarter.
On 08/16/2022, S&P 500 ETF TRUST ETF traded for a price of $428.86 per share and a market cap of $394.50Bil. The stock has returned -2.46% over the past year.
GuruFocus gives the ETF a financial strength rating of 5 out of 10 and a profitability rating of 8 out of 10.
In terms of valuation, S&P 500 ETF TRUST ETF has a price-earnings ratio of 20.29, a price-book ratio of 3.87, a price-earnings-to-growth (PEG) ratio of 2.44, a EV-to-Ebitda ratio of 15.24 and a price-sales ratio of 3.02.
The price-to-GF Value ratio is 0.00, earning the stock a GF Value rank of 6.
SPDR Gold Shares ETF
Quantitative Investment Management, LLC reduced their investment in ARCA:GLD by 268,270 shares. The trade had a 5.24% impact on the equity portfolio. During the quarter, the stock traded for an average price of $174.73.
On 08/16/2022, SPDR Gold Shares ETF traded for a price of $165.71 per share and a market cap of $56.94Bil. The stock has returned -0.41% over the past year.
There is insufficient data to calculate the stock’s financial strength and profitability ratings.
Consumer Discretionary Select Sector SPDR
The guru established a new position worth 176,743 shares in ARCA:XLY, giving the stock a 3.7% weight in the equity portfolio. Shares traded for an average price of $157.69 during the quarter.
On 08/16/2022, Consumer Discretionary Select Sector SPDR traded for a price of $171.08 per share and a market cap of $17.36Bil. The stock has returned -5.12% over the past year.
There is insufficient data to calculate the stock’s financial strength and profitability ratings.
In terms of valuation, Consumer Discretionary Select Sector SPDR has a price-earnings ratio of 25.48 and a price-book ratio of 6.43.
Meta Platforms Inc
The guru established a new position worth 146,251 shares in NAS:META, giving the stock a 3.59% weight in the equity portfolio. Shares traded for an average price of $193.38 during the quarter.
On 08/16/2022, Meta Platforms Inc traded for a price of $180.89 per share and a market cap of $486.15Bil. The stock has returned -50.19% over the past year.
GuruFocus gives the company a financial strength rating of 8 out of 10 and a profitability rating of 10 out of 10.
In terms of valuation, Meta Platforms Inc has a price-earnings ratio of 14.98, a price-book ratio of 3.86, a price-earnings-to-growth (PEG) ratio of 0.56, a EV-to-Ebitda ratio of 9.61 and a price-sales ratio of 4.20.
The price-to-GF Value ratio is 0.47, earning the stock a GF Value rank of 4.
SPDR Biotech ETF
The guru established a new position worth 317,362 shares in ARCA:XBI, giving the stock a 3.59% weight in the equity portfolio. Shares traded for an average price of $75.3 during the quarter.
On 08/16/2022, SPDR Biotech ETF traded for a price of $94.9 per share and a market cap of $8.76Bil. The stock has returned -23.85% over the past year.
There is insufficient data to calculate the stock’s financial strength and profitability ratings.
In terms of valuation, SPDR Biotech ETF has a price-book ratio of 3.54.
Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.
Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!
This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.
